# Fair Drug Prices for Kids Act

This bill gives states the option to use the same drug price negotiation system for children's health insurance that they already use for Medicaid. Right now, when states buy prescription drugs through Medicaid (the health program for low-income adults), they can negotiate lower prices with drug manufacturers through a rebate program. This bill would let states extend that same money-saving approach to the Children's Health Insurance Program (CHIP), which covers kids whose families earn too much to qualify for Medicaid but can't afford private insurance.

The practical effect is straightforward: if a state chooses to participate, it could get better deals on medications for children covered under CHIP. Drug manufacturers would be required to offer the same discounts to CHIP that they offer to Medicaid. This means states could potentially save money on prescription drugs for children, and those savings could be reinvested in expanding coverage or improving other aspects of the program. For families, this could mean lower out-of-pocket costs for children's medications or better access to drugs that might otherwise be too expensive.

The bill doesn't require states to do anything—it's optional. States that want to keep their current system can do so. But for states that choose to participate, the mechanics are already well-established since they've been using this rebate system for Medicaid for years. The bill essentially removes a barrier that currently prevents states from using this proven cost-control method for children's health insurance, giving them another tool to stretch their healthcare budgets further.

Fair Drug Prices for Kids Act

Wild, Susan

Fair Drug Prices for Kids Act This bill allows states to apply the requirements of the Medicaid Drug Rebate Program to covered outpatient drugs under the Children's Health Insurance Program (CHIP).